Company intends to file an IND in Q4 2026 for its first RedTail lead candidate, CLD-401, a systemically delivered and…
Images below confirm clinical responses seen in patients with metastatic orbital (eye), temporal (brain), liver, and spine lesions No Bria-IMT™…
Interim results from Phase 2b clinical trial of RAD 101 showed 92% of evaluable participants met the primary endpoint of…
OCALA, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the…
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - January 28, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)…
DANA POINT, CA AND IRVINE, CA / ACCESS Newswire / January 27, 2026 / The Patient Safety Movement Foundation (PSMF)…
ALEXANDRIA, Va., Jan. 27, 2026 /PRNewswire/ -- The Center for Innovation & Value Research (Center) today announced the appointment of Marc…
Collaboration builds on high-performing Clinically Integrated Network for Commercial and Medicare Advantage to improve outcomes and care coordination for New…
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.VANCOUVER, BC, Jan. 27, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – The global medical imaging market…
The expansion builds on existing client engagements and growing demand for regional execution supportPHILADELPHIA, Jan. 27, 2026 /PRNewswire/ -- Orchestra…